Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2.

Nat Biomed Eng · 2025 · PMC12003156 · PMID 40044817

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Deep sequencing of these libraries revealed a clear trend in mutational distribution based on the different ratios, highlighting the tunable nature of our approach (Fig. 2e ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.